Our team: Cure Leukaemia

James McLaughlin, the chief executive of the blood cancer charity that works to bring pioneering treatments to patients in the Midlands, takes us behind the scenes of the fundraising team

James McLaughlin
James McLaughlin

How many fundraisers are in your team?

We're a team of six, including three fundraisers, based in the heart of Birmingham's Jewellery Quarter.

What does the team do?

We raise money to support the Centre for Clinical Haematology at the QE Hospital, Birmingham, and to fund a network of specialist nurses across the West Midlands. Recently, we were one of the main charities supported by Free Radio's Walk For Kids. It raised money for our £1m campaign, Cure Leukaemia for Kids, to support drugs trials for young leukaemia patients at Birmingham Children's Hospital.

How much do you raise?

We raised a record £514,000 last year, resulting in a 100 per cent increase in funding for specialist nurses. Most of this was down to our partnership with the BBC West Midlands Red Alert Appeal, which brought in more than £100,000 in 2012.

What's in the pipeline?

We are currently celebrating our 10th anniversary. We're also building up a strong team of more than 300 runners to take part in the Bupa Great Birmingham Run in October. We are working on innovative campaigns with Stiliyan Petrov, the former Aston Villa FC player and leukaemia patient, and other partners.

What's it like in the office?

It's a lively place. We're always in and out meeting patients, community fundraisers and our teams at hospitals around the region, so there is never a dull day.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus